@dakotasrelatable's TRT research advice, fact-checked

What does this video actually claim?

@dakotasrelatable tells viewers to "do your research" about TRT without providing specific claims or information to evaluate. The video relies entirely on this general directive rather than making substantive statements about testosterone replacement therapy.

This creates a fact-checking challenge. There's no medical information to verify or contradict. The creator simply encourages research without offering guidance on what to research or how to evaluate sources.

The video's brevity and lack of specific content makes it impossible to assess medical accuracy. It's essentially a four-word recommendation wrapped in TRT-related hashtags.

Is "doing your research" actually good advice for TRT?

Yes and no. Reading about TRT before treatment makes sense, but most people can't properly evaluate testosterone research without medical training. The phrase "do your research" has become code for rejecting mainstream medical advice in favor of online sources.

TRT research requires understanding study design, hormone physiology, and individual risk factors. The Testosterone Trials (Snyder et al., NEJM, 2016) showed modest benefits for sexual function and mood in men over 65, but also raised cardiovascular concerns that require professional interpretation.

Patient education matters, but it shouldn't replace medical consultation. The best approach combines reliable sources with physician guidance, not independent internet research.

What research should people actually know about TRT?

The evidence for TRT is more limited than many realize. The Testosterone Trials found improvements in sexual desire and walking distance, but no significant changes in vitality or cognitive function in older men with low testosterone.

Cardiovascular risks remain unclear. A 2013 study by Vigen et al. suggested increased heart attack risk, but later research like the TRAVERSE trial (Lincoff et al., NEJM, 2023) found no excess cardiovascular events with testosterone gel over 33 months.

Most concerning: many men starting TRT don't actually have clinically low testosterone. Normal ranges vary from 300-1000 ng/dL, and single low readings don't justify treatment without symptoms and repeat testing.

What's missing from this research advice?

The video ignores the quality problem with TRT information online. Social media and men's health websites often promote TRT benefits while downplaying risks or the need for medical supervision.

"Research" without context leads men to questionable sources. TRT clinics market heavily online, sometimes to men with normal testosterone levels who don't need treatment.

Real research means understanding that TRT requires lifelong commitment, can reduce fertility, and may increase prostate cancer detection rates. It's not a simple optimization hack despite what online communities suggest.

What should you actually know about TRT research?

Start with your actual testosterone levels, measured twice in morning blood draws. Levels below 300 ng/dL with symptoms like reduced libido, fatigue, or mood changes might warrant treatment discussion.

The benefits are modest even in appropriate candidates. Sexual function improvements are the most consistent finding, while energy and mood benefits vary significantly between individuals.

Risks include potential cardiovascular effects, reduced fertility, sleep apnea worsening, and prostate monitoring requirements. These need professional evaluation, not internet research.